Evaluation of plasma expanding effects of Hydroxyethyl starches (RCT)

Evaluation of plasma expanding effects of Hydroxyethyl starches (RCT) - Plasma expanding effects of HES (Intraoperative evaluation)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016035

Enrollment

100

Registered

2014-12-23

Start date

2014-12-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TKA or UKA planed patients under general ansethesia

Interventions

HES130/0.4 infusion group (starting from induction of general anesthesia) HES70/0.55 infusion group (starting from induction of general anesthesia) cristaloid infusion group (starting from indu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients planned to have TKA or UKA operation with using tourniquet

Exclusion criteria

Exclusion criteria: patients with severe complications tourniquet duration less than 30 minutes

Design outcomes

Primary

Measure	Time frame
hemodynamic stabilities	—

Secondary

Measure	Time frame
changes of stroke volume variation volume of used vasopressor drugs renal function (BUN,Cre)	—

Countries

Japan

Contacts

Public ContactHiroko Iwakiri

Tokyo Women's Medical University department of Anesthesiology

mkthrk@ff.em-net.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026